Preliminary Efficacy of an mHealth Intervention in West Africa

NCT ID: NCT07276321

Last Updated: 2025-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-03

Study Completion Date

2027-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We are conducting a pilot feasibility and preliminary efficacy trial of a digital intervention for serious mental illness in West Africa.

Participants will be recruited from a large psychiatric hospital in Ghana and randomized into one of three study conditions: 1) Treatment as usual; 2) FOCUS intervention; 3) G-FOCUS intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenic Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment as Usual

Group Type NO_INTERVENTION

No interventions assigned to this group

FOCUS

Group Type ACTIVE_COMPARATOR

FOCUS

Intervention Type OTHER

An evidence-based (USA populations tested) digital tool for serious mental illness.

G-FOCUS

Group Type EXPERIMENTAL

G-FOCUS

Intervention Type OTHER

A cultural adaption of an evidence-based (USA populations tested) digital tool for serious mental illness

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

G-FOCUS

A cultural adaption of an evidence-based (USA populations tested) digital tool for serious mental illness

Intervention Type OTHER

FOCUS

An evidence-based (USA populations tested) digital tool for serious mental illness.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 18 years of age or older
2. Speaks English
3. Outpatient receiving care at Accra Psychiatric Hospital
4. Diagnosis of Schizophrenic Spectrum Disorder
5. Owns a mobile device capable of downloading smartphone applications

Exclusion Criteria

1. Hearing, vision, or motor impairment that would hamper their ability to participate in data collection
2. Serious intellectual or developmental disability that would hamper their ability to participate in data collection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Washington

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dror Ben-Zeev

Professor: School of Medicine, Psychiatry and Behavioral Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dror Ben-Zeev, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Accra Psychiatric Hospital

Accra, , Ghana

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Ghana

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alexa Beaulieu

Role: CONTACT

253 261-8661

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kwadwo Obeng, MBChB, MGCP, FGCP

Role: primary

+233 20 253 6108

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00023050

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Trial to Increase FEP Attendance
NCT05967195 ACTIVE_NOT_RECRUITING EARLY_PHASE1